Company News

Gynesonics Names Industry Veteran Skip Baldino President and CEO, Announces $25M Financing to Expand Worldwide Commercialization

REDWOOD CITY, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced that Skip Baldino was appointed in early March to the role of President and Chief Executive Officer of the company. Mr. [...]

2023-04-13T10:58:51+01:00April 13th, 2023|All News, Company News|

Medartis announces completion of a CHF 30 million capital increase to finance its additional stake in Keri Medical

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Basel, 17 March 2023: Medartis Holding AG (SIX: MED), an orthopaedic company specialising in head and extremity surgery, today announced the successful completion of a small capital increase of CHF 30 million in a private placement to finance an additional stake [...]

2023-05-02T10:31:51+01:00March 17th, 2023|All News, Company News|

The Innovation Continues for Robotic-Assisted Surgery – Virtual Incision Completes FDA Investigational Device Exemption (IDE) Clinical Study for MIRA

Study results will be used to support the first FDA De Novo request for market authorization of the MIRA Surgical System as Virtual Incision makes progress towards its mission to expand RAS access Lincoln, Neb. – February 22, 2023 – Virtual Incision Corporation, a medical device company spearheading the [...]

2023-03-28T14:20:01+01:00February 22nd, 2023|All News, Company News|

Miach Orthopaedics Secures $40 Million Financing – Funds to Expand U.S. Commercialization of BEAR® Implant for Treatment of ACL Tears

WESTBOROUGH, Massachusetts – January 24, 2023 – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced closing of a $40 million financing round. The funds will enable ongoing operations and expand [...]

2023-03-28T14:20:57+01:00January 25th, 2023|All News, Blog, Company News, Investment, Medtech|

HealthJoy Raises $60M Series D to Power HR Leaders Through a New Era of Workplace and Healthcare Benefits

CHICAGO, Oct. 27, 2022 - HealthJoy, a healthcare navigation platform that drives benefits satisfaction, improves care outcomes, improves employee satisfaction and reduces HR burden, today announced it has raised $60M in Series D funding. Valspring Capital led the round with participation from new investors Endeavour Vision and CIBC Innovation [...]

2023-03-28T14:41:47+01:00October 27th, 2022|All News, Blog, Company News, Investment, Medtech|

Endeavour Vision adds Kestra Medical Technologies to EMG II Portfolio

Endeavour Vision is pleased to announce the addition of Kestra Medical Technologies to its portfolio – a company poised to disrupt the billion-dollar wearable cardioverter defibrillator (WCD) market. Kestra is bringing much-needed innovation to patients at risk of sudden cardiac arrest. Kestra’s ASSURE WCD automatically detects the irregularities in [...]

2023-03-28T14:42:45+01:00August 26th, 2022|All News, Blog, Company News, Investment, Medtech|

Nalu Medical, Inc. Names Thomas West President and Chief Executive Officer

CARLSBAD, CALIFORNIA, July 14, 2022 – Nalu Medical, Inc. (“Nalu”), a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced today that the Board of Directors has appointed Thomas “Tom” West as President and Chief Executive Officer. This leadership appointment is effective on August [...]

2023-02-22T12:06:39+00:00July 15th, 2022|All News, Company News|

FLEX Vessel Prep AV Registry Data Shows A Longer Lasting Solution to Standalone PTA When Treating AV Access Fistulas and Grafts

MINNEAPOLIS, June 15, 2022 /PRNewswire/ -- VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced data presented at the Vascular Access Societies of the Americas (VASA) June 9-11, [...]

2023-03-28T14:44:46+01:00June 21st, 2022|All News, Company News|

Medartis completes acquisition of Nextremity Solutions Inc. and announces new US leadership

Basel, Switzerland, 3 May 2022 - Medartis Holding AG (SIX: MED) announced today that it has completed the acquisition of Nextremity Solutions Inc., a strategic commercialisation organisation located in Warsaw, USA. The total purchase price for the transaction will be up to USD 70 million and includes milestone and [...]

2023-04-03T11:19:57+01:00May 3rd, 2022|All News, Company News|

Virtual Incision Announces Approval to Complete Clinical Study Enrollment for its MIRA® Platform

FDA decision supported by an interim clinical study report on patient safety Lincoln, Neb. – April 19, 2022 – Virtual Incision Corporation, a medical device company pioneering the world’s first miniaturized robotic-assisted surgery (RAS) platform, today announced the U.S. Food and Drug Administration (FDA) has approved an Investigational Device [...]

2023-03-28T14:49:36+01:00April 20th, 2022|All News, Company News|
Go to Top